...
首页> 外文期刊>The journal of clinical endocrinology and metabolism >Glucose Intolerance in Pregnancy and Postpartum Risk of Metabolic Syndrome in Young Women
【24h】

Glucose Intolerance in Pregnancy and Postpartum Risk of Metabolic Syndrome in Young Women

机译:葡萄糖耐量在年轻妇女的妊娠和代谢综合征的产后风险中

获取原文
           

摘要

Context/Objective: Gestational diabetes mellitus (GDM) and even mild glucose intolerance in pregnancy are both associated with increased risks of developing type 2 diabetes and cardiovascular disease in the future. Because the metabolic syndrome also identifies patients at risk of type 2 diabetes and cardiovascular disease, we hypothesized that gestational dysglycemia may be associated with an unrecognized latent metabolic syndrome. Thus, we sought to evaluate the relationship between gestational glucose tolerance status and postpartum risk of metabolic syndrome.Design/Setting/Participants: In this prospective cohort study, 487 women underwent oral glucose tolerance testing in pregnancy and cardiometabolic characterization at 3 months postpartum. The antepartum testing defined three gestational glucose tolerance groups: GDM (n = 137); gestational impaired glucose tolerance (GIGT) (n = 91); and normal glucose tolerance (NGT) (n = 259).Main Outcome Measure: The primary outcome was the presence of the metabolic syndrome at 3 months postpartum, as defined by International Diabetes Federation (IDF) and American Heart Association/National Heart Lung and Blood Institute (AHA/NHLBI) criteria, respectively.Results: The postpartum prevalence of IDF metabolic syndrome progressively increased from NGT (10.0%) to GIGT (17.6%) to GDM (20.0%) (overall P = 0.016). The same progression was observed for AHA/NHLBI metabolic syndrome (NGT, 8.9%; GIGT, 15.4%; and GDM, 16.8%; overall P = 0.046). On logistic regression analysis, both GDM (odds ratio, 2.05; 95% confidence interval, 1.07–3.94) and GIGT (odds ratio, 2.16; 95% confidence interval, 1.05–4.42) independently predicted postpartum metabolic syndrome.Conclusions: Both GDM and mild glucose intolerance in pregnancy predict an increased likelihood of metabolic syndrome at 3 months postpartum, supporting the concept that women with gestational dysglycemia may have an underlying latent metabolic syndrome.
机译:背景/目的:妊娠期糖尿病(GDM)甚至妊娠中的轻度葡萄糖不耐症都与将来患2型糖尿病和心血管疾病的风险增加有关。因为代谢综合症还可以识别出有2型糖尿病和心血管疾病风险的患者,所以我们假设妊娠期血糖异常可能与无法识别的潜在代谢综合症有关。因此,我们试图评估妊娠期糖耐量状态与产后代谢综合征风险之间的关系。设计/背景/参与者:在这项前瞻性队列研究中,有487名妇女在妊娠和产后3个月进行了心脏代谢测试,并进行了口服糖耐量测试。产前测试定义了三个妊娠期葡萄糖耐量组:GDM(n = 137);妊娠葡萄糖耐量减低(GIGT)(n = 91);主要结果指标:主要结局指标是:国际糖尿病联盟(IDF)和美国心脏协会/美国国家心肺协会(National Heart Lung)定义为产后3个月出现代谢综合征。结果:IDF代谢综合征的产后患病率从NGT(10.0%)升至GIGT(17.6%)到GDM(20.0%)逐渐增加(总体P = 0.016)。对于AHA / NHLBI代谢综合征,观察到了相同的进展(NGT,8.9%; GIGT,15.4%; GDM,16.8%;总体P = 0.046)。在逻辑回归分析中,GDM(赔率,2.05; 95%置信区间,1.07–3.94)和GIGT(赔率,2.16; 95%置信区间,1.05-4.42)均独立预测产后代谢综合征。妊娠中的轻度葡萄糖不耐受症预示着产后3个月代谢综合征的可能性增加,这支持了妊娠期血糖异常的女性可能患有潜在的潜在代谢综合征的观念。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号